We are live on
!
Find out more
RMCM
Reynders McVeigh Capital Management Portfolio holdings
AUM
$1.98B
1-Year Est. Return
23.37%
This Fund
S&P 500
This Quarter
Est. Return
+2.79%
1 Year Est. Return
+23.37%
3 Year Est. Return
+85.22%
5 Year Est. Return
+113.19%
10 Year Est. Return
+523.93%
AUM
$337M
AUM Growth
–
Cap. Flow
+$338M
Cap. Flow
% of AUM
100.17%
Top 10 Holdings %
Top 10 Hldgs %
35.56%
Holding
146
New
146
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$20.1M |
| 2 |
CVS Health
CVS
|
+$15.5M |
| 3 |
Automatic Data Processing
ADP
|
+$12.3M |
| 4 |
Johnson & Johnson
JNJ
|
+$12.2M |
| 5 |
Novartis
NVS
|
+$11.6M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 30.51% |
| 2 | Technology | 24.65% |
| 3 | Industrials | 13.85% |
| 4 | Consumer Staples | 11.53% |
| 5 | Financials | 4.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Procter & Gamble
PG
$339B
| $19.8M | 5.86% |
+256,620
| New | +$20.1M |
|
|
2
CVS Health
CVS
$122B
| $15.2M | 4.52% |
+266,691
| New | +$15.5M |
|
|
3
Automatic Data Processing
ADP
$108B
| $12.4M | 3.69% |
+205,898
| New | +$12.3M |
|
|
4
Johnson & Johnson
JNJ
$625B
| $12.3M | 3.65% |
+143,261
| New | +$12.2M |
|
|
5
Novartis
NVS
$297B
| $11.3M | 3.36% |
+178,557
| New | +$11.6M |
|
6
Johnson Controls International
JCI
$92.2B
| $10.8M | 3.2% |
+288,016
| New | +$10.7M |
|
7
GSK
GSK
$106B
| $10.6M | 3.15% |
+170,228
| New | +$10.8M |
|
8
Emerson Electric
EMR
$88.3B
| $10M | 2.97% |
+183,339
| New | +$10.3M |
|
9
Teva Pharmaceuticals
TEVA
$41.2B
| $9.34M | 2.77% |
+238,351
| New | +$9.28M |
|
|
EMC
10
DELISTED
EMC CORPORATION
EMC
| $8.05M | 2.39% |
+340,757
| New | +$8.04M |
|
11
Cisco
CSCO
$479B
| $7.46M | 2.21% |
+306,548
| New | +$6.9M |
|
12
Walmart Inc
WMT
$890B
| $7.37M | 2.19% |
+296,970
| New | +$7.61M |
|
13
Labcorp
LH
$25.9B
| $6.89M | 2.04% |
+80,151
| New | +$6.65M |
|
14
Illumina
ILMN
$28.4B
| $6.42M | 1.9% |
+88,130
| New | +$5.64M |
|
15
NXP Semiconductors
NXPI
$60.4B
| $6.41M | 1.9% |
+206,730
| New | +$6.05M |
|
16
Apple
AAPL
$4.57T
| $6.23M | 1.85% |
+440,048
| New | +$6.77M |
|
17
Canadian National Railway
CNI
$76.6B
| $6.11M | 1.81% |
+125,618
| New | +$6.19M |
|
18
Intel
INTC
$513B
| $6.09M | 1.81% |
+251,193
| New | +$5.93M |
|
19
Stratasys
SSYS
$774M
| $6.01M | 1.78% |
+71,827
| New | +$5.79M |
|
20
Perrigo
PRGO
$1.78B
| $6.01M | 1.78% |
+49,705
| New | +$5.89M |
|
21
AptarGroup
ATR
$8.61B
| $5.99M | 1.78% |
+108,497
| New | +$6.1M |
|
22
Wolfspeed
WOLF
$1.71B
| $5.73M | 1.7% |
+89,826
| New | +$5.26M |
|
23
Rockwell Automation
ROK
$49B
| $5.65M | 1.68% |
+67,965
| New | +$5.87M |
|
24
Corning
GLW
$143B
| $5.26M | 1.56% |
+369,400
| New | +$5.37M |
|
25
Mastercard
MA
$493B
| $5.14M | 1.53% |
+89,550
| New | +$4.97M |
|
Similar funds
SC
CAM
TCM
RCM
LGM
MYAM
HA
NIM
Reynders McVeigh Capital Management's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Reynders McVeigh Capital Management, which disclosed 146 positions worth $337M. Its ten largest holdings account for 36% of the portfolio.
Its largest position is Procter & Gamble: 256,620 shares worth $19.8M.
By sector, the portfolio is most concentrated in Healthcare at 31% of assets, followed by Technology and Industrials.
- Reynders McVeigh Capital Management's largest Q2 2013 buy was Procter & Gamble: 256,620 shares worth $19.8M.
- Reynders McVeigh Capital Management's ten largest holdings make up 36% of its $337M portfolio in Q2 2013.
- Reynders McVeigh Capital Management disclosed 146 positions in Q2 2013, its first 13F filing on record.
Based on Reynders McVeigh Capital Management's 13F filing for Q2 2013, filed 12 Aug 2013.